The Gilead Sciences Research Scholars Program (RSP) in Public Health is a global initiative structured to support the professional growth of early-career junior investigators and public health professionals. By funding country-driven research priorities, the program addresses critical knowledge gaps and underserved areas in global health equity.
​The program focuses specifically on emerging public health professionals originating from or working in low- and middle-income countries who are dedicated to driving innovations in HIV and viral hepatitis research. This comprehensive guide outlines the operational steps, key dates, and strategic components required to successfully submit an application for this competitive cycle.
​Quick Summary Box
| Feature | Details |
|---|---|
| Sponsoring Body | Gilead Sciences |
| Program Track | Global Public Health Research Scholars Program |
| Target Audience | Early-career researchers, junior faculty, and public health practitioners from low- and middle-income countries. |
| Disease Focus Areas | Public health impacts and interventions concerning HIV and viral hepatitis. |
| Total Grant Funding | Up to $100,000 USD distributed over a 2-year project period. |
| Upcoming Informational Session | July 15, 2026, at 3:00 PM CET. |
| Final Proposal Deadline | August 28, 2026, at 11:59 PM CEST. |
Â
Opportunity Overview
The Gilead RSP in Public Health aims to foster institutional research capacity where funding opportunities are traditionally limited. Unlike clinical trials funded to test specific pharmaceuticals, this grant explicitly focuses on implementation science, health inequities, and local care delivery strategies.
​Through this program, Gilead supports up to four junior researchers globally per cycle. The objective is to help early-career investigators establish independent, sustainable research portfolios that generate peer-reviewed manuscripts, abstracts, and the primary data required to secure future large-scale international grants.
​Benefits
- ​Two-Year Financial Security: Total financial support of up to $100,000 USD, disbursed to the scholar's host institution in two annual installments of up to $50,000 USD.
- ​Indirect Cost Inclusion: The total grant allotment includes permissible institutional overhead/indirect costs, preventing out-of-pocket operational strain on local laboratories.
- ​Access to Experts: Selected scholars are mentored by an independent Scientific Review Committee composed of established international leaders in global public health.
- ​Global Networking Platforms: Recipients receive invitations to awards acknowledgment sessions and research forums hosted by Gilead, connecting them with an international community of potential collaborators.
​Eligibility Criteria
- ​Academic Appointment Status: Applicants must currently hold a junior faculty position, postdoctoral research position, or an equivalent early-career tracking role within an academic research institution, public health organization, ministry of health, or hospital.
- ​Degree Requirements: Candidates must hold an M.D., PhD, MBBS, MBChB, or equivalent terminal research/medical degree at the time of submission.
- ​Career Window Constraints: Applicants must be within 10 years of their terminal degree graduation.
- ​Time Commitment Guarantee: The applicant must prove institutional support allowing them to devote a minimum of 50% of their total professional time directly to research (shielding them from excessive teaching, clinical care, or administrative duties).
- ​Mentorship Mandate: Each applicant must have an identified, in-country primary research mentor with an established track record of independent funding and scientific productivity in a related field. Co-mentorship structures are acceptable.
​Eligible Healthcare Professions
The multidisciplinary nature of implementation science allows applications from a variety of early-career specialists, including:
- ​Epidemiologists and public health specialists
- ​Infectious disease fellows and junior clinical faculty
- ​Health policy analysts and implementation scientists
- ​Biostatisticians and medical sociologists studying underserved health delivery systems
IMG/International Applicant Considerations
- ​Focus on Developing Nations: The program explicitly targets researchers from low- and middle-income countries and regions.
- ​Visa Validation: If the applicant is pursuing research outside their country of origin, they must possess a valid work visa or non-immigrant permit covering the entire 2-year duration of the grant.
- ​Country-Driven Focus: Rather than executing Western-designed studies, the research questions must be locally prioritized, country-driven, and designed to match the health realities of the host country environment.
Required Documents
Applications are submitted entirely in English through Gilead's online grants portal and must feature the following core items:
- ​Comprehensive Project Narrative: A detailed research proposal mapping out the background, specific aims, significance, methodology, and limitations of the public health project.
- ​Itemized Budget & Narrative Justification: A line-by-line financial blueprint detailing how the $50,000 annual installment will be broken down.
- ​Mentor’s Letter of Support & Mentoring Plan: A dedicated statement from the local mentor detailing their track record, allocated laboratory or office infrastructure, and a specific timeline for professional development check-ins.
- ​Department Chair’s Institutional Commitment Letter: A formal institutional sign-off confirming that the applicant will receive the mandatory 50% protected research time.
- ​Curriculum Vitae (CV): Complete academic portfolios for both the primary investigator and the mentor, detailing relevant abstracts, publications, and presentations.
​Application Process
- ​Portal Registration: Create an account profile on the official Gilead Research Scholars digital platform.
- ​Attend the Webinar: Participate in the voluntary Zoom Informational Session on July 15, 2026, to interface with the Scientific Review Committee regarding program scopes and focus areas.
- ​Draft Specific Aims: Refine your project proposal to match the rigorous, double-blind peer-review expectations.
- ​Institutional Approval Tracking: Route the proposal locally to secure the required letters of support from mentors and department chairs.
- ​Final Upload: Submit the full application package through the online portal before the closing time on August 28, 2026.
​Tips to Increase Your Chances
- ​Prioritize Innovation & Feasibility: The committee looks for creative approaches to public health challenges that can realistically be completed within the 2-year award window.
- ​Draft a Highly Detailed Mentoring Plan: Proposals with generic letters of recommendation rarely score well. Ensure your mentor provides a clear, structured plan illustrating how they will actively guide your career development.
- ​Focus on Local Translation: Clearly articulate how your findings will translate into actionable improvements for public health, patient outcomes, or health policy within your specific region.
​Common Mistakes to Avoid
- ​Proposing Research on Gilead Products: Applications that focus on evaluating specific Gilead pharmaceuticals, comparing branded treatments, or conducting product-specific safety/efficacy studies are strictly ineligible and will be screened out.
- ​Tokenizing the Protected Time Mandate: If your institutional commitment letter fails to clearly guarantee the 50% protected research time window, the application will be disqualified.
- ​Ignoring the Second-Year Progression Rules: Funding for Year 2 is not automatic. It is contingent on submitting a formal progress report that must be approved by the Chair of the Scientific Review Committee.
- ​Seeking Duplicative Funding: The program does not allow duplicative funding for projects currently supported by other international pharmaceutical or federal grants.
​Application Timeline
The 2026 public health application timeline moves through the following fixed progression:
- ​May–June 2026: Online application portal opens for digital portfolio submissions.
- ​July 15, 2026 (3:00 PM CET): Virtual informational Zoom session hosted by the Scientific Review Committee.
- ​August 28, 2026 (11:59 PM CEST): Strict final deadline for uploading complete applications via the online platform.
- ​September–November 2026: Comprehensive blind peer review by the independent Scientific Review Committee.
- ​Late Q4 2026: Official announcement of the selected four Gilead Research Scholars and grant activation.
​Deadline
- ​August 28, 2026 at 11:59 PM Central European Summer Time (CEST).
​FAQs
​Q: Can I apply for this public health track if my research focuses on oncology or Covid-19?
A: No. The specific focus of the Public Health track of the Research Scholars Program is bounded to health outcomes, epidemiology, and interventions regarding HIV and/or viral hepatitis.
​Q: What is the purpose of the upcoming July informational session?
A: The Zoom webinar allows potential applicants to connect directly with members of the Scientific Review Committee to clarify program expectations, scientific scope, and optimal research proposals before finalizing submission materials.
​Q: Is there flexibility on the 10-year post-degree requirement for applicants who took a career break?
A: The program enforces a standard 10-year ceiling from the terminal degree. However, applicants with unique parental, medical, or humanitarian career interruptions are advised to check the official FAQ or reach out to the platform administration to confirm individual alignment.
​Official Link(s)
​Final Thoughts
The Gilead Sciences 2026 Research Scholars Program in Public Health represents an exceptional launchpad for junior faculty and early-career clinicians striving to overcome structural research barriers in low- and middle-income countries. By offering up to $100,000 USD alongside high-caliber mentorship, the program bridges the gap between local implementation challenges and global health scientific visibility. For researchers ready to advance country-driven data in HIV and viral hepatitis, compiling your institutional sign-offs and attending the July 15 informational webinar is the optimal strategy to position your proposal for success.
Leave a Comments
Login to comment
No comments yet.